Skip to search formSkip to main contentSkip to account menu

eplerenone

Known as: eplerenon, 9,11alpha-Epoxy-17-hydroxy-3-oxo-17alpha-pregn-4-ene-7alpha,21-dicarboxylic acid, gamma-lactone, Methyl Ester, eplerenone [Chemical/Ingredient] 
A selective aldosterone receptor antagonist. Eplerenone binds to the mineralocorticoid receptor and blocks the binding of aldosterone, thereby… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Introduction: A simple stability indicating reverse-phase high-performance liquid chromatographic (RP-HPLC) method has been… 
2016
2016
Eplerenone (EPL), a selective aldosterone receptor antagonist, is indicated in the treatment of chronic heart failure and… 
2013
2013
Objective: To develop and evaluate Eplerenone (EP) microspheres using natural polymer like Chitosan. Eplerenone is a suitable… 
2012
2012
A simple reverse phase gradient HPLC method used for simultaneous identification of Eplerenone impurities in market tablet dosage… 
2011
2011
The transformation of cardiac care over the past half century has been breathtaking to witness. In large part, this… 
2011
2011
1. Department of Health and Human Services. OPTN/SRTR annual report 2009. (http://optn.transplant.hrsa.gov/ar2009.) 2. Haynes L… 
2011
2011
The combination should be used with caution because of the risk of hyperkalaemia 
2010
2010
Heart failure: Placing an EMPHASIS on the mineralocorticoid receptor—benefit of eplerenone in mild HF 
Review
2005
Review
2005
The benefits of aldosterone receptor antagonists (spironolactone and eplerenone) for patients with heart failure were shown in 2… 
2000
2000
AbstractPurpose. The present study was conducted to characterize the pharmacokinetics of eplerenone (EP), a selective aldosterone…